Microchip Technology Incorporated

Q3/FY Dec quarter performance (good): beat guidance and improved profitability - Net sales: $1.186B, +4% sequentially and +15.6% YoY, above the high end of original guidance. - Non-GAAP gross margin: 60.5% (includes $51.7M capacity underutilization + $58.4M inventory reserves). - Non-GAAP EPS: $0.44, $0.04 above the top end of original guidance. - Non-GAAP operating margin: 28.5%; cash flow: $341.4M operating cash flow, $305.6M adjusted free cash flow. - Surprising/positive: March-like margin expectations were achieved earlier—management said they expected the “six-handle” non-GAAP gross margin only by March, but reached it in December.

Guidance for March quarter (forecast/upside but still uncertainty): growth + margin range - Net sales: $1.26B ± $20M → midpoint implies +6.2% sequential and +29.8% YoY. - Non-GAAP gross margin: 60.5%–61.5% (midpoint ~61%). - Non-GAAP OpEx: 31.3%–31.7% of sales; Non-GAAP operating profit: 28.8%–30.2% of sales. - Non-GAAP diluted EPS: $0.48–$0.52. - Key framing: guidance assumes normalizing inventory reserves but acknowledges underutilization charges still remain a material drag.

Balance-sheet / cash return (good with disciplined deleveraging; shareholder return continuing) - Inventory at Dec 31: $1.058B, down $37.6M from Sep 30; distributors’ sell-in vs sell-through gap narrowed to $11.7M (from $52.9M in September), signaling inventory correction. - Cash & investments: $250.7M total cash/investments position. - Debt/net leverage improved: net debt decreased $26M sequentially; net debt / adj. EBITDA = 4.18 (down from 4.69). - Capex: $22.5M in Dec; FY2026 capex expected ≤ $100M. - Dividends/buybacks: management said excess free cash flow above dividends will continue to be used to reduce borrowing (no major new buyback authorization discussed in the Q&A excerpt).